Category Archives: Parkinson’s Treatment

Parkinson's Disease victim appeals for people to show patience 9:26am Wednesday 23rd April 2014 in News A PARKINSONS Disease sufferer has appealed for people to be patient when they come across those afflicted by the 'horrible' condition. James DeLittle was speaking as he revealed that pioneering treatment he underwent in Kiev earlier this year had sadly failed to transform his condition. He said he considered his illness a life sentence, which he wouldn't wish on his worst enemy, but it was made even worse by other people's impatience, or assumption that he was drunk. He contacted The Press to make a special plea to readers: "Next time you are in a the back of a queue and are thinking: "For goodness sake, what is this guy doing? What's taking so long?" or "You're clearly drunk. I can't understand a word you said," just wait a minute. "All we ask from you is please be patient and don't ignore us and start to talk to the person we are with - that is so annoying -just give us a little more time to explain." Mr DeLittle, 49, of Broadway West, Fulford, hit the headlines earlier this year when he went to … Continue reading →

The most effective way to tackle debilitating diseases is to punch them at the start and keep them from growing. Research at Michigan State University, published in the Journal of Biological Chemistry, shows that a small "molecular tweezer" keeps proteins from clumping, or aggregating, the first step of neurological disorders such as Parkinson's disease, Alzheimer's disease and Huntington's disease. The results are pushing the promising molecule toward clinical trials and actually becoming a new drug, said Lisa Lapidus, MSU associate professor of physics and astronomy and co-author of the paper. "By the time patients show symptoms and go to a doctor, aggregation already has a stronghold in their brains," she said. "In the lab, however, we can see the first steps, at the very place where the drugs could be the most effective. This could be a strong model for fighting Parkinson's and other diseases that involve neurotoxic aggregation." Lapidus' lab uses lasers to study the speed of protein reconfiguration before aggregation, a technique Lapidus pioneered. Proteins are chains of amino acids that do most of the work in cells. Scientists understand protein structure, but they don't know how they are built -- a process known as folding. Lapidus' lab … Continue reading →

PUBLIC RELEASE DATE: 21-Apr-2014 Contact: Layne Cameron Layne.cameron@cabs.msu.edu 517-353-8819 Michigan State University EAST LANSING, Mich. --- The most effective way to tackle debilitating diseases is to punch them at the start and keep them from growing. Research at Michigan State University, published in the Journal of Biological Chemistry, shows that a small "molecular tweezer" keeps proteins from clumping, or aggregating, the first step of neurological disorders such as Parkinson's disease, Alzheimer's disease and Huntington's disease. The results are pushing the promising molecule toward clinical trials and actually becoming a new drug, said Lisa Lapidus, MSU associate professor of physics and astronomy and co-author of the paper. "By the time patients show symptoms and go to a doctor, aggregation already has a stronghold in their brains," she said. "In the lab, however, we can see the first steps, at the very place where the drugs could be the most effective. This could be a strong model for fighting Parkinson's and other diseases that involve neurotoxic aggregation." Lapidus' lab uses lasers to study the speed of protein reconfiguration before aggregation, a technique Lapidus pioneered. Proteins are chains of amino acids that do most of the work in cells. Scientists understand protein structure, … Continue reading →

A group of scientists from the University of Kentucky College of Medicine and the Sanders-Brown Center on Aging has found interesting new information in a study on depression and neuropsychological function in Parkinson's disease (PD). Published in the journal Psychiatry Research, the study, which assessed cognitive function in depressed and non-depressed patients with PD, found that the dopamine replacement therapy commonly used to treat motor symptoms of Parkinson's disease was associated with a decline in cognitive performance among depressed Parkinson patients. In contrast, non-depressed Parkinson patients' cognitive function improved on dopamine replacement therapy. The study also found that mood in depressed Parkinson's patients was actually worse while on dopaminergic medications. "This was a surprise," said Lee Blonder, Ph.D., the study's principal investigator. "It is the opposite of our original hypothesis that both groups of PD patients would improve in cognitive performance on dopaminergic medications, and that mood in the depressed PD group would also improve." A cohort of 28 patients with PD -- 18 nondepressed and 10 depressed -- were given a baseline series of tests to assess cognitive function and the incidence and severity of depression. They were then re-tested with and without their dopamine replacement therapy. Results revealed … Continue reading →

Stem cell treatment for Parkinsons A patient was suffering from Rheumatoid Arthitis Parkinsons and was treated by Stem cell therapy.After the treatment Patient is able to walk fast.for more ... By: StemRx BioScience … Continue reading →

Contact Information Available for logged-in reporters only Newswise LEXINGTON, Ky. (April 21, 2014) -- A group of scientists from the University of Kentucky College of Medicine and the Sanders-Brown Center on Aging has found interesting new information in a study on depression and neuropsychological function in Parkinson's disease (PD). Published in the journal Psychiatry Research, the study, which assessed cognitive function in depressed and non-depressed patients with PD, found that the dopamine replacement therapy commonly used to treat motor symptoms of Parkinson's disease was associated with a decline in cognitive performance among depressed Parkinson patients. In contrast, non-depressed Parkinson patients cognitive function improved on dopamine replacement therapy. The study also found that mood in depressed Parkinson's patients was actually worse while on dopaminergic medications. "This was a surprise," said Lee Blonder, Ph.D., the study's principal investigator. "It is the opposite of our original hypothesis that both groups of PD patients would improve in cognitive performance on dopaminergic medications, and that mood in the depressed PD group would also improve." A cohort of 28 patients with PD -- 18 nondepressed and 10 depressed -- were given a baseline series of tests to assess cognitive function and the incidence and severity of … Continue reading →

WEST HARTFORD, Conn., April 15,2014 /PRNewswire-iReach/ -- Global Information Inc. announces the addition of a new market research report "Deep Brain Stimulation Devices Market for Parkinson's Disease (North America, Europe, Asia-Pacific and Latin America) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019" at GIIResearch.com A rise in the world's aging population, increase in the number of patients living with Parkinson's disease and growing awareness about neurological movement disorders among patients have triggered the growth of deep brain stimulation devices market. Globally, neurological disorders are the main causes of mortality; these account for approximately 12% of total number of deaths. Of these, cerebrovascular diseases are responsible for 85% of deaths. Parkinson's disease is the most common neurodegenerative movement disorder after Alzheimer's. Symptoms associated with this disease include tremors, slowness of movement, muscle stiffness and trouble with balance. Drug therapy is the most effective treatment option available to control Parkinson's disease in the initial stages; however, a large number of medicines are required to control the disease during the advanced stages. In late stage of the disease, deep brain stimulation (DBS) surgical treatment is used to control the involuntary symptoms. DBS is an effective, clinically proven and … Continue reading →

Comments(0) WHEN former BBC producer Anna Parkinson was diagnosed with a brain tumour in 2002 her whole world crashed down around her. And with doctors deeming it too dangerous operate, her life became a waiting game. But as her symptoms worsened, the mother-of-two from Sissinghurst Road in Biddenden decided to take her health into her own hands and follow an alternative and often derided treatment in the form of healing. Ten years on from her diagnosis, her brain tumour has now virtually disappeared and the 59-year-old puts it down to healing. For about 18 months after being diagnosed I paddled around going to see specialists expecting I was going to have some miracle operation, she said. But I was having scans and my symptoms were getting steadily worse. I had this voice going on in my head. You react to shock and I just began to listen to it. It was like an internal dialogue. People offered me healing and really I would have taken anything. I was open-minded. I wanted the problem to go away so I could get on with my life. I was aware the fear and the panic was getting worse. My eyesight was completely flipped … Continue reading →

Bob McClay Reporter Years with the company: I started on January 2, 2006. Education: I was born in San Antonio, Texas, but we moved to Phoenix when I was one-year-old in 1957. I grew up here and graduated from Alhambra High School and attended Phoenix College. Family: I am married to my wife Rene', who is a librarian in the Washington school district. During free time, I may be found playing basketball in the driveway with my son, Devin. He's also keeping me busy with school, Little League, and playing in chess tournaments around the Valley. Favorite food: Lots of favorite food, but our favorite restaurant is Fajitas. Favorite spot in Arizona: The Little America Hotel in Flagstaff. Favorite news memory: We have to go back to October 15, 1979. I was a country music air personality at KROP Radio in Brawley, California, when we had a 6.7 earthquake. Thankfully, there were no deaths and only minor injuries, but the entire community was pretty freaked out and listening to the station on their transistor radios. I would not want to go through an earthquake again, but it sure was a great night to work in radio and see how it … Continue reading →

PUBLIC RELEASE DATE: 10-Apr-2014 Contact: Shawna Williams shawna@jhmi.edu 410-955-8236 Johns Hopkins Medicine Working with human neurons and fruit flies, researchers at Johns Hopkins have identified and then shut down a biological process that appears to trigger a particular form of Parkinson's disease present in a large number of patients. A report on the study, in the April 10 issue of the journal Cell, could lead to new treatments for this disorder. "Drugs such as L-dopa can, for a time, manage symptoms of Parkinson's disease, but as the disease worsens, tremors give way to immobility and, in some cases, to dementia. Even with good treatment, the disease marches on," says Ted Dawson, M.D., Ph.D., professor of neurology and director of the Johns Hopkins Institute for Cell Engineering, Dawson says the new research builds on a growing body of knowledge about the origins of Parkinson's disease, whose symptoms appear when dopamine-producing nerve cells in the brain degenerate. Further evidence for a role of genetics in Parkinson's disease appeared a decade ago when researchers identified key mutations in an enzyme known as leucine-rich repeat kinase 2, or LRRK2 pronounced "lark2." When that enzyme was cloned, Dawson, together with his wife and longtime collaborator … Continue reading →